Clinical Trial Analysisfor "HealthPartners Institute"
Study Phases Distribution
Distribution of trials by study phase
Not Applicable: 94
Phase 2: 20
Phase 1: 14
Phase 4: 13
Phase 3: 10
Early Phase 1: 1
Recruitment Status Distribution
Distribution of trials by recruitment status
Total: 196
Top Countries Distribution
Countries with most clinical trials
Top Companies Distribution
Companies with most clinical trials
| Company | Count |
|---|---|
| HealthPartners Institute | 153 |
| Eli Lilly and Company | 4 |
| Seagen, a wholly owned subsidiary of Pfizer | 3 |
| Amgen | 2 |
| Arkadiusz Z. Dudek, MD | 2 |
| Hennepin Healthcare Research Institute | 2 |
| Abbott Diabetes Care | 1 |
| Anaveon AG | 1 |
| Arcus Biosciences, Inc. | 1 |
| Arjun Balar, MD | 1 |
Top Conditions Distribution
Most studied medical conditions
| Condition | Count |
|---|---|
| Type 2 Diabetes | 13 |
| Hypertension | 12 |
| Obesity | 9 |
| Diabetes | 8 |
| Type 1 Diabetes | 7 |
| Dementia | 5 |
| Diabetes Mellitus | 5 |
| Hyperlipidemia | 5 |
| Alzheimer Disease | 4 |
| Breast Cancer | 4 |
Top Interventions Distribution
Most common intervention types
| Intervention | Count |
|---|---|
| Placebo | 15 |
| Clinical Decision Support | 3 |
| Insulin glulisine | 3 |
| Nivolumab | 3 |
| pembrolizumab | 3 |
| Acupuncture | 2 |
| Control | 2 |
| Docetaxel | 2 |
| Infinitome | 2 |
| Insulin Degludec | 2 |